Medical research for hire : the political economy of pharmaceutical clinical trials / Jill A. Fisher.

Format:

Book

Author/Creator:

Fisher, Jill A., 1976-

Series:

Critical issues in health and medicine

Language:

English

Subjects (All):

Drugs--Testing--Economic aspects--United States.

Drugs.

Clinical trials--Economic aspects--United States.

Clinical trials.

Drugs--Testing--Moral and ethical aspects--United States.

Clinical trials--Moral and ethical aspects--United States.

Contracting out--United States.

Contracting out.

Clinical trials--Moral and ethical aspects.

Drugs--Testing--Moral and ethical aspects.

Drugs--Testing.

Drugs--Testing--Economic aspects.

United States.

Drug Industry--ethics.

Clinical Trials as Topic--ethics.

Research Subjects.

Medical Subjects:

Drug Industry--ethics.

Clinical Trials as Topic--ethics.

Research Subjects.

Physical Description:

x, 257 pages ; 23 cm.

Place of Publication:

New Brunswick, N.J. : Rutgers University Press, [2009]

Summary:

Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians.

According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums, and inflated overhead costs to operate private practices, they are attracted to pharmaceutical contract research for its lucrative return. Clinical trials also provide limited medical access to individuals who have no or inadequate health insurance because trials offer "free" doctors' visits, diagnostic tests, and medications to participants. Focusing on the professional roles of those involved, as well as key research practices, Fisher assesses the risks and advantages for physicians and patients alike when pharmaceutical drug studies are used as an alternative to standard medical care.

Contents:

Clinical trials: coming soon to a physician near you

Governing human subjects research

Pursuing contract research

Coordinating clinical trials

Monitoring the clinical trials industry

Recruiting human subjects

Mobilizing informed consent

Cultivating pharmaceutical "compliance"

Changing markets in pharmaceutical research.

Notes:

Includes bibliographical references (pages 221-244) and index.

ISBN:

9780813544090

0813544092

9780813544106

0813544106

OCLC:

195767411